Syneos Health
Acquired- Employees
- 10001+
- Business Model
- B2B
- Acquisition Date
- May 2023
About
Syneos Health is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success, translating clinical, medical affairs, and commercial insights into outcomes that address modern market realities. The company combines therapeutic depth, shared insights, and advanced technology, including AI-driven performance tools, to speed customers' delivery of important therapies to patients. With more than 26,000 employees, 480+ MDs, and 750+ PhDs, Syneos Health has helped develop or commercialize 96% of oncology drugs and 89% of central nervous system drugs approved by the FDA in the last five years.
Summary
Syneos Health is a Biotech company based in United States. Investors include Elliott Management, Patient Square Capital and Veritas Capital.
Tech & App Stack
6 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
May 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company